How to Acquire Antibiotics for Sale

In the old days, no one can acquire antibiotics for sale if they do not have a doctor’s prescription for it.   Most people of those ages do think that it is rightly appropriate to first have a doctor’s prescription or at least his recommendation in order for one to be allowed to get some antibiotics for sale to treat their ailments, but today, due to modern advancements in science, health and technology, this way of thinking is now being overlooked.  The way most of us think about antibiotics today is also different, too.  When we get a bacterial infection, we would usually want to get it treated right away, and that’s what antibiotics for sale without a prescription is all about.

You may be wondering, how can one acquire antibiotics for sale without a prescription by a doctor? If you live in the United States or any similar country, then most of the times it would be difficult for you to be able to buy some antibiotics for sale right at your local pharmacy’s counter.  In reality, there is a way on how to get some antibiotics for sale even without a doctor’s prescription on hand, and there are actually 4 ways: through a pet store, take a trip to Mexico, visit an oriental/ethnic market or convenience store, or you can buy antibiotics for sale via the Internet.

If you are already a pet lover or you have a pet at home, for example, a fish, then any pharmacist will say to you that human antibiotics are usually used to treat fish diseases, and you do not need a prescription just to buy antibiotics for your pet fish.  Some antibiotics for sale available at pet stores where you do not need a prescription are: ampicillin, erythromycin, tetracycline in either tablet or capsule form. Most people would think it’s not a great idea to take vet medicines; however, in chemical form, these drugs are actually the same as what you will get from a local pharmacy meant for human use. Read more…

Future looks bleak for Avandia as safety trial put on hold

Last week saw an rule that there is reason to believe the troubled diabetes drug Avandia (rosiglitazone) does indeed increase cardiovascular risks compared to its direct competitor Actos (pioglitazone).

Now, the FDA appears to be moving to shut down the Canadian-led trial that represented the last chance for maker GlaxoSmithKline to prove its drug is safe. The agency put a "partial clinical hold" on new recruitment for the trial while it updates the lead investigators - Drs Salim Yusef and Hertzel Gerstein of McMaster University - on the results of last week's panel meeting.

While the FDA safety panel stopped short of voting to remove Avandia from the market, the agency can still take action without a vote, and most observers suspect the end is near for Avandia, which has already seen sales collapse in the wake of data suggesting it increases cardiovascular events.

In fact, the same safety concerns were inhibiting recruitment to the TIDE trial. GSK, which agreed in 2007 to fund a head-to-head comparison with pioglitazone, said last week that only 1,100 of an intended 16,000 study participants have volunteered to date.

1 comments:

sharon(aka Purley Quirt ) said...

I would like to see/know who is behind the thrust to use diabetes medication as a prophylactic measure ( including insulin).

Is this ever increasing drug dependent society ( at every level) ever going to ask who is behind it?

I am very intrigued by this new push by pharmacia to make physicians feel the time they spend on alternates to drugs ( teaching, training, lifestyle change)is a sign of ? failing to serve the best interests of the patient .